BioNTech SE (BNTX) Exchange Rate Effect (2018 - 2025)
BioNTech SE's (BNTX) quarterly Exchange Rate Effect came in at $1.6 million in Q4 2025, down 88.79% year-on-year from $14.5 million in Q4 2024, and up 106.48% quarter-over-quarter from -$25.1 million in Q3 2025.
BioNTech SE (BNTX) Exchange Rate Effect (2018 - 2025) Analysis & Trends
BioNTech SE has disclosed Exchange Rate Effect across 8 years of filings, most recently posting $1.6 million for Q4 2025.
- Exchange Rate Effect for Q4 2025 came in at $1.6 million, down 88.79% year-over-year; the trailing twelve-month figure through Dec 2025 was -$30.0 million (down 289.55% YoY), and the FY2025 annual result was -$30.5 million, down 292.88% from the prior year.
- Exchange Rate Effect came in at $1.6 million for Q4 2025 at BioNTech SE, up from -$25.1 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $865.0 million in Q4 2022 to a low of -$105.2 million in Q4 2021.
- The 5-year median for Exchange Rate Effect is $4.5 million (2024), against an average of $88.0 million.
- Across the five-year window, Exchange Rate Effect plunged 191894673.21% in 2021 and surged 1959797846.1% in 2022, its largest moves.
- BioNTech SE's Exchange Rate Effect stood at -$105.2 million in 2021, then surged by 921.86% to $865.0 million in 2022, then sank by 101.92% to -$16.6 million in 2023, then soared by 187.71% to $14.5 million in 2024, then tumbled by 88.79% to $1.6 million in 2025.
- The last three Exchange Rate Effect figures came in at $1.6 million (Q4 2025), -$25.1 million (Q3 2025), and $10.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | BioNTech SE | 27.38 Bn | 10.07 Bn | 668.28 Mn | 1.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.63 Mn |
| Dec 31, 2025 | 1.63 Mn |
| Sep 30, 2025 | -25.13 Mn |
| Sep 30, 2025 | -25.13 Mn |
| Jun 30, 2025 | 10.41 Mn |
| Jun 30, 2025 | 10.41 Mn |
| Mar 31, 2025 | -16.94 Mn |
| Mar 31, 2025 | -16.94 Mn |
| Dec 31, 2024 | 14.53 Mn |
| Dec 31, 2024 | 14.53 Mn |
| Sep 30, 2024 | -2.53 Mn |
| Sep 30, 2024 | -2.53 Mn |
| Jun 30, 2024 | -3.55 Mn |
| Jun 30, 2024 | -3.55 Mn |
| Mar 31, 2024 | 7.39 Mn |
| Mar 31, 2024 | 7.39 Mn |
| Dec 31, 2023 | -16.57 Mn |
| Dec 31, 2023 | -16.57 Mn |
| Sep 30, 2023 | 66.62 Mn |
| Sep 30, 2023 | 66.62 Mn |